Genzyme Corporation et al v. Gland Pharma Limited
| Genzyme Corporation and Sanofi-Aventis U.S. LLC |
| Gland Pharma Limited |
| 1:2018cv01071 |
| July 19, 2018 |
| US District Court for the District of Delaware |
| Wilmington Office |
| New Castle |
| Kent A Jordan |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 27, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 8 WAIVER OF SERVICE returned executed by Sanofi-Aventis U.S. LLC, Genzyme Corporation: For Gland Pharma Limited waiver sent on 7/19/2018, answer due 10/17/2018. (Bove, Jeffrey) |
| Filing 7 REQUEST FOR WAIVER of Service sent to Gland Pharma Limited on 7/19/2018 by Genzyme Corporation, Sanofi-Aventis U.S. LLC. Waiver of Service due by 9/17/2018. (Bove, Jeffrey) |
Filing 6
ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Kent A. Jordan of the United States Court of Appeals for the Third Circuit. Signed by the Honorable D. Brooks Smith, Chief Judge of the United States Court of Appeals for the Third Circuit, on 8/6/18. (rjb)
|
| Case Assigned to Judge Kent A. Jordan of the United States Court of Appeals for the Third Circuit. Please include the initials of the Judge (KAJ) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Genzyme Corporation, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE42,152 E; US 7,897,590 B2; US 6,987,102 B2. (ceg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/7/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 12/7/2020. (ceg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Gland Pharma Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2422639.) - filed by Sanofi-Aventis U.S. LLC, Genzyme Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet)(ceg) |
| No Summons Issued. (ceg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
